Aerospace & Defense
Agriculture
Automotive & Transportation
Banking & Finance
Chemicals & Materials
Construction & Manufacturing
Electronics & Communication
Energy & Power
Food & Beverages
Healthcare & Life Sciences
Heavy Industry
Information Technology
Packaging
Retails & Consumer
Our
Clients
Search Reports
: Aug, 2020
: 100
:
Industry Overview
The global healthcare BPO market size is projected to reach USD 755.76 billion by 2031, growing at a CAGR of 9.49 %. The need to contain rising healthcare expenses, the increased demand for specialized services like fraud detection and care management, as well as the requirement for structured processes and paperwork in the healthcare business, are all factors contributing to the market expansion. On the other side, some of the key elements anticipated to impede market expansion are worries about data security and privacy as well as the worry of losing visibility and control over company processes.
Source: AMR
The segment hospital BPO sector is rapidly expanding due to the outsourcing of clinical procedures as well as a decrease in errors in non-critical activities like accounting, financing, and customer services. The key forces for the development of the medical BPO sector are, in fact, the necessity for protection, the requirement to lower healthcare costs, and the threat of patent peaks for the pharmaceutical business. This puts more strain on those providing healthcare services.
Market Dynamics
The financial model for important suppliers to the nursing service activity has been strengthened by their greater contribution to improving patient care, population health, and aiding healthcare providers in cost-optimization. Additionally, information security would be at risk. Information security is a concern because contracting exposes a lot of sensitive information to any third party. Additionally, there are questions concerning the quality of the services given because it's possible that a service provider isn't really concerned or interested in offering alternatives or therapies to the parties involved as much as their primary business is. These substances are expected to act as growth inhibitors.
Companies take into account the environment in the medical BPO business. A variety of temporary tasks are typically transferred using outsourcing, which lowers operating costs. Among the key end customers are manufacturing, drug development, marketing, and statistics. In the hospital BPO sector, clinical coding and accounting, expenditure reports, and information processing procedures are becoming more and more in demand.
COVID Impact
Healthcare BPO services have been impacted by Covid-19 in addition to other businesses. One of the top industries, it anticipates improving both the quality of its services and the productivity of its workforce. It seeks to provide top-notch patient care, which will boost business revenue. Additionally, it is certain that patients will recommend or return to a healthcare facility, especially if they have a favourable experience there.
The Coronavirus emergency has antagonistically affected practically all areas universally, with disturbed supply chains, vast lockdown and associations investigating the chance of long haul and, surprisingly, super durable remote working. The majority of industries and businesses have been profoundly affected by Covid-19. The impact that Covid-19 has had on business in some ways is unprecedented. Additionally, it has compelled a number of businesses to scramble to adjust. Covid-19's impact on the healthcare BPO sector remains complex and multifaceted. Changes to accommodate its effects are still being implemented by several healthcare BPO services.
The healthcare BPO industry is extremely fortunate to operate digitally, allowing BPO firms to continue operating with minimal risks to employees' health and safety. In order to maintain their virtual peak performance, healthcare BPO services have undergone a number of technological and digital transformations. Covid-19 has a significant and far-reaching effect on the BPO sector. We'll go into more detail below about some of the most pressing changes.
Regional Trend
With 49.0% of the market, North America dominated, followed by Europe (30.6%) and the Rest of the World had the least of all the regions. As a result of Medicare Prescription Drug Coverage (Part D), which provides coverage for prescription drugs for all Medicare beneficiaries, pharmaceutical companies in the region, particularly the United States, are experiencing significant pressures related to drug prices. Furthermore, the patent lapse of a few blockbuster drugs is supposed to influence the income of enormous drug organizations in the US and Canada. Due to these considerations, a number of pharmaceutical companies are focusing on cost reduction through outsourcing, which is ultimately propelling North American market expansion.
Regional share.png
Source:AMR
The huge reception embraced by significant market members in the market as well as the critical information on the potential heading ns clinical IT arrangements is credited with the extension of both the market area. Because of an observable expense of medical services use, the presence of enormous organizations, as well as headways, this country came in second inside the clinical BPO industry. The medical BPO industry as a whole is expanding at the fastest rate in the world, offering significant growth potential.
Competitive Landscape
?The key players have a strong foothold in the market and offer a wide range of services. Some of the key players in this market are Accenture (Ireland), Cognizant (US), Infosys BPM (India), IBM Corporation (US), IQVIA (US), TCS (India), Wipro (India), and WNS (Holdings) Ltd. (India) are some of the major players in this market. Other player active in the market are Access Healthcare, Akurate Management Solutions, Firstsource Solutions, GeBBS Healthcare Solutions, Genpact, HCL Technologies, Invensis Technologies, Lonza, Mphasis, NTT Data Corporation, Omega Healthcare, Parexel International, R1 RCM, Sutherland Global, Sykes Enterprises, UnitedHealth Group and Xerox Corporation.
By Provider Service
By Payer Service
By Life Science Service
Global Healthcare BPO Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Healthcare BPO market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Global Healthcare BPO Market: Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Frequently Asked Questions
What is the market size and growth projections?
What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
What are the top performing segments, and countries / regions of each of the markets?
What is the market size and growth rate across key countries / regions?
How big is the global & regional market in terms of revenue and volume?
How far market will grow in forecast period in terms of revenue and volume?
What factors will influence demand and supply trends across each markets during the forecast period?
What are the technology trends shaping various markets?
Which country / region has more opportunities?
What is the COVID-19 impact on the market and how long will it take to recover?
Who are the key competitors of market Players?
What are the market share (%) of Key Players?
What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
1. Global Healthcare BPO Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Healthcare BPO Scope and Market Estimation
1.2.1.Global Healthcare BPO Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2032)
1.2.2.Global Healthcare BPO Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2032
1.3. Market Segmentation
1.3.1.Provider Service of Global Healthcare BPO
1.3.2.Payer Services of Global Healthcare BPO
1.3.3.Life Science Services of Global Healthcare BPO
1.3.4.Region of Global Healthcare BPO
2. Executive Summary
3. Market Factor Analysis
3.1. Global Healthcare BPO Industry Trends under COVID-19 Outbreak
3.1.1.Global COVID-19 Status Overview
3.1.2.Influence of COVID-19 Outbreak on Global Healthcare BPO Industry Development
3.2. Market Dynamics, By Region
3.2.1.Drivers
3.2.2.Limitations
3.2.3.Opportunities
3.2.4.Impact Analysis of Drivers and Restraints
3.3. Ecosystem / Value Chain Analysis
3.3.1.Raw Materials / Components Suppliers
3.3.2.Manufacturers / Vendors
3.3.3.Distributors
3.3.4.Buyers / End-users
3.3.5.Forward Integration & Backward Integration of Key Stakeholders
3.4. Global Healthcare BPO - Pricing Trends Analysis & Average Selling Prices (ASPs)
3.5. End-User / Customer Preferences & Consumer Surveys
3.6. Technology Roadmap & Key Innovations /Developments
3.7. Key Mandates & Regulatory Scenario Analysis
3.8. Patents Landscape
3.9. Manufacturing Cost Structure Share Analysis
3.10. Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.
3.11. Porters Five Forces Analysis
3.11.1. Bargaining Power of Suppliers
3.11.2. Bargaining Power of Buyers
3.11.3. Threat of Substitutes
3.11.4. Threat of New Entrants
3.11.5. Competitive Rivalry
3.12. PEST Analysis
3.12.1. Political Factors
3.12.2. Economic Factors
3.12.3. Social Factors
3.12.4. Technological Factors
3.13. SWOT Analysis
3.14. Russia-Ukraine War Impacts Analysis
3.15. ANSOFF Matrix
3.15.1. Market Penetration Strategy
3.15.2. Product Development Strategy
3.15.3. Market Development Strategy
3.15.4. Diversification Strategy
3.16. Inflation Impacts Analysis
3.16.1. Supply Side Impacts
3.16.2. Demand Side Impacts
3.16.3. Outlook in 2023 & Beyond
3.17. Market Investment Feasibility Analysis
3.18. Opportunity Map Analysis
3.19. Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Regions
4. Global Healthcare BPO Estimates & Historical Trend Analysis (2019 - 2022)
5. Global Healthcare BPO Estimates & Forecast Trend Analysis, by Provider Service
5.1. Global Healthcare BPO Revenue (US$ Mn) Estimates and Forecasts, by Provider Service, 2019 to 2032
5.1.1.Revenue Cycle Management
5.1.2.Patient Enrolments
5.1.3.Patient Care
5.1.3.1. Medical Transcription
5.1.3.2. Medical Imaging
5.1.3.3. Device Monitoring
6. Global Healthcare BPO Estimates & Forecast Trend Analysis, by Payer Service
6.1. Global Healthcare BPO Revenue (US$ Mn) Estimates and Forecasts, by Payer Service, 2019 to 2032
6.2. Claims Management
6.2.1.Claims Adjudication Services
6.2.2.Claims Settlement Services
6.2.3.Information Management Services
6.2.4.Claims Repricing
6.2.5.Claims Investigation Services
6.2.6.Claims Indexing Services
6.2.7.Fraud Detection & Management
6.3. Product Development & Business Acquisition (PDBA)
6.4. Member Management
6.5. Provider Management
6.6. Care Management
6.7. Integrated Front-End Services and Back-office Operations
6.8. Billing and accounts management services
6.9. HR Services
7. Global Healthcare BPO Estimates & Forecast Trend Analysis, by Life Science Service
7.1. Global Healthcare BPO Revenue (US$ Mn) Estimates and Forecasts, by Life Science Service, 2019 to 2032
7.2. Manufacturing
7.3. R&D
7.4. Non-Clinical Services
7.4.1.Supply Chain Management & Logistics
7.4.2.Sales and Marketing Services
7.4.2.1. Forecasting
7.4.2.2. Performance Reporting
7.4.2.3. Analytics
7.4.2.4. Research
7.4.2.5. Marketing
7.4.3.Other Non-Clinical Services
8. Global Healthcare BPO Estimates & Forecast Trend Analysis, by Region
8.1. Global Antibody-Drug Conjugates Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2032
8.1.1.North America
8.1.2.Europe
8.1.3.Asia Pacific
8.1.4.Middle East & Africa
8.1.5.South America
9. North America Healthcare BPO: Estimates & Forecast Trend Analysis
9.1. North America Antibody-Drug Conjugates Market Assessments & Key Findings
9.1.1.Healthcare BPO Introduction
9.1.2.Healthcare BPO Size Estimates and Forecast (US$ Million) (2019 2031)
9.1.2.1. By Payer Service
9.1.2.2. By Life Science Service
9.1.2.3. By Provider Service
9.1.2.4. By Country
9.1.2.4.1. The U.S.
9.1.2.4.2. Canada
9.1.2.4.3. Mexico
10. Europe Healthcare BPO: Estimates & Forecast Trend Analysis
10.1. Europe Healthcare BPO Assessments & Key Findings
10.1.1. Healthcare BPO Introduction
10.1.2. Healthcare BPO Size Estimates and Forecast (US$ Million) (2019 2031)
10.1.2.1. By Payer Service
10.1.2.2. By Life Science Service
10.1.2.3. By Provider Service
10.1.2.4. By Country
10.1.2.4.1. Germany
10.1.2.4.2. U.K.
10.1.2.4.3. France
10.1.2.4.4. Italy
10.1.2.4.5. Spain
10.1.2.4.6. Russia
10.1.2.4.7. Rest of Europe
11. Asia Pacific Healthcare BPO: Estimates & Forecast Trend Analysis
11.1. Asia Pacific Market Assessments & Key Findings
11.1.1. Healthcare BPO Introduction
11.1.2. Healthcare BPO Size Estimates and Forecast (US$ Million) (2019 2031)
11.1.2.1. By Payer Service
11.1.2.2. By Life Science Service
11.1.2.3. By Provider Service
11.1.2.4. By Country
11.1.2.4.1. China
11.1.2.4.2. Japan
11.1.2.4.3. India
11.1.2.4.4. Australia
11.1.2.4.5. South Korea
11.1.2.4.6. ASEAN
11.1.2.4.7. Rest of Asia Pacific
12. Middle East & Africa Healthcare BPO: Estimates & Forecast Trend Analysis
12.1. Middle East & Africa Market Assessments & Key Findings
12.1.1. Healthcare BPO Introduction
12.1.2. Healthcare BPO Size Estimates and Forecast (US$ Million) (2019 2031)
12.1.2.1. By Payer Service
12.1.2.2. By Life Science Service
12.1.2.3. By Provider Service
12.1.2.4. By Country
12.1.2.4.1. U.A.E.
12.1.2.4.2. Saudi Arabia
12.1.2.4.3. Egypt
12.1.2.4.4. South Africa
12.1.2.4.5. Rest of Middle East & Africa
13. South America Healthcare BPO: Estimates & Forecast Trend Analysis
13.1. South America Market Assessments & Key Findings
13.1.1. Healthcare BPO Introduction
13.1.2. Healthcare BPO Size Estimates and Forecast (US$ Million) (2019 2031)
13.1.2.1. By Payer Service
13.1.2.2. By Life Science Service
13.1.2.3. By Provider Service
13.1.2.4. By Country
13.1.2.4.1. Brazil
13.1.2.4.2. Argentina
13.1.2.4.3. Colombia
13.1.2.4.4. Rest of South America
14. Competition Landscape
14.1. Healthcare BPO Competition Index, By Leading Players
14.2. Healthcare BPO Competition White Space Analysis, By Application / End-user
14.3. Healthcare BPO Competition Heat Map Analysis, By Products / Services / Solutions
14.4. Healthcare BPO Competition Regional Intensity Map Analysis, By Geographies Served
14.5. Healthcare BPO Concentration & Company Market Shares (%) Analysis, 2022
14.6. Healthcare BPO Competition Quadrant Analysis, By Leading Players / Innovators / Emerging Players / New Entrants
15. Company Profiles
15.1. Accenture (Ireland)
15.1.1. Company Overview & Key Stats
15.1.2. Financial Performance & KPIs
15.1.3. Product / Service / Solutions Portfolio & Applications / End-uses
15.1.4. Business Strategy & Recent Developments
* Similar details would be provided for all the players mentioned below
15.2. Cognizant (US),
15.3. Infosys BPM (India),
15.4. IBM Corporation (US),
15.5. IQVIA (US),
15.6. TCS (India),
15.7. Wipro (India),
15.8. WNS (Holdings) Ltd. (India)
15.9. Access Healthcare,
15.10. Akurate Management Solutions,
15.11. Firstsource Solutions,
15.12. GeBBS Healthcare Solutions,
15.13. Genpact,
15.14. HCL Technologies,
15.15. Invensis Technologies,
15.16. Lonza,
15.17. Mphasis,
15.18. NTT Data Corporation,
15.19. Omega Healthcare,
15.20. Parexel International,
15.21. R1 RCM,
15.22. Sutherland Global,
15.23. Sykes Enterprises,
15.24. UnitedHealth Group
15.25. Xerox Corporation
15.26. Others
16. Research Methodology
16.1. External Sources / Databases
16.2. Internal Proprietary Database
16.3. Primary Research
16.4. Secondary Research
16.5. Assumptions
16.6. Limitations
16.7. Report FAQs
17. Research Findings & Conclusion
